Zorevunersen Data for Dravet Syndrome Presented at EPNS Congress
Biogen and Stoke Therapeutics have presented new data on zorevunersen, their investigational antisense oligonucleotide for Dravet syndrome, further solidifying...
eClinical Tech News
Gozellix Gets Permanent HCPCS Code
Telix Pharmaceuticals has secured a permanent Healthcare Common Procedure Coding System (HCPCS) Level II code (A9616) from the U.S....
Nurix Q2 2025 Financial Results & Corporate Update
Nurix Therapeutics, a clinical-stage biotech focused on targeted protein degradation, reported positive financial results for Q2 2025, driven by...
Turnstone Biologics to be Acquired by Xoma for $0.34/Share + CVR
XOMA Royalty Corporation will acquire Turnstone Biologics for $0.34 per share in cash plus one non-transferable contingent value right...